The University of Texas at Dallas
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, The University of Texas at Dallas sits in the top decile of US sponsors by registered trial count (#377 of 15,742 sponsors by registered trial count).
The University of Texas at Dallas: 50 sponsored US clinical trials, 14 recruiting.
The University of Texas at Dallas sponsors 50 registered US clinical trials on ClinicalTrials.gov, 14 of them currently recruiting, and 26 completed. The most-studied condition in this pipeline is Autism, with 3 trials.
Top-decile sponsor footprint
The University of Texas at Dallas ranks in the top decile of sponsors by registered trial count (#377 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
26 of 33 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (78.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
50 total, page 1 of 1
Clinical and Neurobehavioral Changes With Weight Loss Drug Discontinuation and Reinitiation
NCT07387796
Using Non-invasive Brain Stimulation to Explore Potential Treatments to Reduce Speech Errors in Adults Who Stutter
NCT07354139
Meeting the Needs of Young Hispanic Autistic Children
NCT06733584
Exploring Neurophysiological Markers of Brain Health
NCT06731452
Use of Airpod Pros as Assistive Technology
NCT06840015
Brain Health on College Campuses
NCT06724887
Targeted Plasticity Therapy for PTSD
NCT06266364
Word Learning From Parentese in Autistic Children
NCT06649916
Evaluating Pathways Mutual Gaze Protocol on Social Skills in Young Children Suspected of Autism
NCT06596226
Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation
NCT05958381
Treating Mild Traumatic Brain Injury With High Definition Transcranial Direct Current Stimulation
NCT04869059
Neural Bases of Vocal Sensorimotor Impairment in Aphasia
NCT04742894
The BrainHealth Project
NCT04869111
Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD
NCT03932773
Treating Primary Progressive Aphasia and Apraxia of Speech Using Non-invasive Brain Stimulation
NCT05368350
Closed-Loop Vagus Nerve Stimulation (CLV) for Recovery of Gait
NCT07689227
Treatment of Cognitive and Sensorimotor Deficits in Parkinson's Disease With High Definition Transcranial Direct Current Stimulation
NCT07534397
Treating Word Finding Difficulties in Traumatic Brain Injury With HD-tDCS
NCT06840808
Breaking Through the Brain Fog: An Online Research Study
NCT05444231
Treating Civilian Traumatic Brain Injury With High Definition Transcranial Direct Current Stimulation (ciTBI-HDtDCS)
NCT05408975
The Efficacy of Neural Stimulation in Individuals With Schizophrenia
NCT05746494
Evaluating the Efficacy of Pathways Parent-Mediated Early Autism Intervention on Social Attention and Language
NCT05604326
Mindfulness and Attention Training Intervention to Lower Distractibility in Aging
NCT05974605
Automated Stereognosis to Treat Loss of Tactile Function After Brain Injury
NCT05740553
Rhythm-based Intervention in Aphasia
NCT04581564
The BrainHealth Project - Pilot Study
NCT04621240
Impact of Challenging Engagement on Cognition in Older Adults
NCT03962439
Improving Visual Attention in Schizophrenia
NCT03880227
Improving Social Interaction for Adolescents With Autism During the Transition to Adulthood
NCT03785327
Brain Energy Metabolism and Sleep in Adults
NCT03929302
Strategic Training to Optimize Neurocognitive Functions in Older Adults
NCT03988829
Executive Function Training Intervention for Chronic Traumatic Brain Injury
NCT03704116
Investigating Memory in Healthy Subjects Using Transcranial Direct Current Stimulation
NCT03564353
Transcranial Direct Current Stimulation for Pain Treatment in Gulf War Illness.
NCT03547869
Investigating Transcranial Direct Current Stimulation (tDCS) in Accelerating Learning in a Healthy Older Population
NCT03467698
Stimulating the Social Brain
NCT03374631
Stimulating the Brain to Improve Self-Awareness
NCT03370341
Technology Development for Physical Rehabilitation of Patients With Upper Extremity Motor Deficits (RePlay)
NCT03621969
Investigating Accelerated Learning and Memory in Healthy Subjects Using a Face Name Memory Task
NCT03309072
Investigating the Neural Correlates in Memory Retrieval After HD-tDCS
NCT03319134
Investigating Neural Processing of Social Stimuli
NCT03380260
Investigating Accelerated Learning in Healthy Subjects: Trigeminal Nerve Stimulation
NCT03138590
Treatment of Memory Disorders in Gulf War Illness With High Definition Transcranial Direct Cortical Stimulation
NCT03542383
Brain and Cognitive Changes After Reasoning Training in Individuals With Mild Cognitive Impairment
NCT02596906
Cognitive Engagement and Aging Mind
NCT05924490
Brain and Cognitive Changes After Reasoning or Physical Training in Cognitively Normal Seniors
NCT00977418
Brain Training to Enhance Frontal Lobe Reasoning
NCT01552473
Cognitive Screening and Cognitive Training in Seniors
NCT02588209
Novel Treatment of Emotional Dysfunction in Post Traumatic Stress Disorder (PTSD)
NCT01391832
Social Cognition Assessment in Young Adults
NCT02922400
Therapeutic Areas
What is open in the The University of Texas at Dallas pipeline
14 recruiting of 50 indexed (28% open); 26 completed (52%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Autism (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
The University of Texas at Dallas: open-pipeline peers nationwide
Peers matched on 50 registered trials and 28% open enrollment, not the therapeutic-area sidebar.
The University of Texas at Dallas sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 50 trials (± recruiting share)
- Carelon Research · 50 trials · 2% recruiting
- Repros Therapeutics · 50 trials · 0% recruiting
- Colgate Palmolive · 51 trials · 6% recruiting
- MedtronicNeuro · 51 trials · 4% recruiting
Sponsors near 28% open enrollment (± trial volume)
- Hanmi Pharmaceutical Company Limited · 28% recruiting · 25 trials
- University of Arkansas, Fayetteville · 28% recruiting · 25 trials
- Merit Medical Systems · 28% recruiting · 18 trials
- 89bio · 29% recruiting · 7 trials
Related
What to do with this The University of Texas at Dallas page
50 registered trials is a research-attention snapshot, not an endorsement of The University of Texas at Dallas or any single study.
- 14 of The University of Texas at Dallas's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Autism is the condition The University of Texas at Dallas studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Autism trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
The University of Texas at Dallas pipeline card: 50 registered trials from official public datasets.Report a data error.